338
Views
11
CrossRef citations to date
0
Altmetric
Hematological Malignancy

Characterization of conserved CDR3 sequence of TCR α- and β-chain genes in peripheral blood T-cells from patients with diffuse large B-cell lymphoma

, , , , &
Pages 48-57 | Published online: 18 Jul 2013

References

  • Mitterlechner T, Fiegl M, Mühlbfick H, Oberaigner W, Dirnhofer S, Tzankov A. Epidemiology of non-Hodgkin-lymphomas in Tyrol/Austria from 1991 to 2000. J Clin Pathol 2006; 59: 48–55.
  • Habermann TM, Weller EA, Morrison VA et al. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol 2006; 24: 3121–3127.
  • Popescu MC, Robb RJ, Batenjany MM et al. A novel proteoli-posomal vaccine elicits potent antitumor immunity in mice. Blood 2007; 109: 5407–5410.
  • Mackensen A, Meidenbauer N, Vogl S, Laumer M, Berger J, Andreesen R. Phase I study of adoptive T-cell therapy using antigen-specific CD8± T cells for the treatment of patients with metastatic melanoma. J Clin Oncol 2006; 24: 5060–5069.
  • Li Y, Yang L, Chen S, Zhang Y, Wu X. The TCR Vbeta repertoireusage of T-cells from cord blood induced by chronic myelogenous leukemia associated antigen. Hematology 2005; 10: 387–392.
  • Mandruzzato S, Rossi E, Bernardi F et al. Large and dissimilar repertoire of Melan-A/MART-1-specific CTL in metastatic lesions and blood of a melanoma patient. J Immunol 2002; 169: 4017–4024.
  • Morgan RA, Dudley ME, Wunderlich JR et al. Cancer regressionin patients after transfer of genetically engineered lymphocytes. Science 2006; 314: 126–129.
  • Gillmore R, Xue SA, Holler A et al. Detection of Wilms' tumorantigen-specific CTL in tumor-draining lymph nodes of patients with early breast cancer. Clin Cancer Res 2006; 12: 34–42.
  • Mommaas B, van Halteren AG, Pool J et al. Adult and cord bloodT cells can acquire HA-1 specificity through HA-1 T-cell receptor gene transfer. Haematologica 2005; 90: 1415–1421.
  • Scholten KB, Schreurs MW, Ruizendaal J.J. et al. Preservation and redirection of HPV16E7-specific T cell receptors for immunother-apy of cervical cancer. Clin Immunol 2005; 114: 119–129.
  • Schultze JL, Cardoso AA, Freeman GJ et al. Follicular lympho-mas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity. Proc Nail Acad Sci USA 1995; 92: 8200–8204.
  • Rezvany MR, Jeddi-Tehrani M, Wigzell H, Osterborg A, Mellstedt H. Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia. Blood 2003; 101: 1063–1070.
  • Yin Q, Li Y, Tan H et al. Identification of specific TCR V#3 and V#13 genes relate to diffuse large B-cell lymphoma-associated antigen. Blood 2007; 110(11): 35B.
  • Li Y, Yin Q, Tan H et al. Identification of specific TRAV6 and TRAV23 genes in peripheral blood T cells from patients with diffuse large B-cell lymphoma. Blood 2007; 110(11): 168B.
  • Puisieux I, Even J, Pannetier C, Jotereau F, Favrot M, Kourilsky P. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J Immunol 1994; 153: 2807–2818.
  • Li Y, Chen S, Yang L et al. TRAY and TRBV repertoire, clonality and the proliferative history of umbilical cord blood T cells. Transpt Immunol 2007; 18: 151–158.
  • WHO-JUTS Nomenclature Sub-Committee on TCR Designation. Nomenclature for T-cell receptor (TCR) gene segments of the immune system. Immunogenetics 1995; 42: 451–453.
  • Moss PH, Bell JI. Comparative sequence analysis of the human T cell receptor TCRA and TCRB CDR3 regions. Hum Immunol 1996; 48: 32–38.
  • Li YQ, Yang Li, Chen SH, Zhang YP, Zhang XL, Luo GX. T cell receptor V# repertoire usage and clonal expansion of Tcells in chronic myelogenous leukemia. Chin Med J 2004; 117: 840–843.
  • Nagymanyoki Z, Butler MO, Callahan MJ et al. Antigen-specific T cell immune response detected by skewed T cell receptor usage in normal placenta and complete molar pregnancy. J Reprod Med 2008; 53: 528–534.
  • Crompton L, Khan N, Khanna R, Nayak L, Moss PA. CD4± T cells specific for glycoprotein B from cytomegalovirus exhibit extreme conservation of T-cell receptor usage between different individuals. Blood 2008; 111: 2053–2061.
  • Kedzierska K, Turner Si, Doherty PC. Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope. Proc Nail Acad Sci USA 2004; 101: 4942–4947.
  • Garrido P, Ruiz-Cabello F, Barcena P et al. Monoclonal TCR-V#13.1 ±/CD4 ±/NKa /CD84±dim T-LGL lymphocytosis: evi-dence for an antigen-driven chronic T-cell stimulation origin. Blood 2007; 109: 4890–4898.
  • Sensi M, Farina C, Maccalli C, Anichini A, Berd D, Parmiani G. Intralesional selection of T cell clonotypes in the immune response to melanoma antigens occurring during vaccination. J Immunother 1998; 21: 198–204.
  • Armstrong KM, Piepenbrink KH, Baker BM. Conformational changes and flexibility in T-cell receptor recognition of peptide-MHC complexes. Biochem J 2008; 415: 183–196.
  • Wang F, Ono T, Kalergis AM et al. On defining the rules for interactions between the T cell receptor and its ligand: a critical role for a specific amino acid residue of the T cell receptor beta chain. Proc Nail Acad Sci USA 1998; 95: 5217–5222.
  • Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 1996; 384: 134–141.
  • Chang HC, Smolyar A, Spoerl R et al. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis. J Mol Biol 1997; 271: 278–293.
  • Zhong W, Dixit SB, Mallis RJ et al. CTL recognition of a protective immunodominant influenza A virus nucleoprotein epitope utilizes a highly restricted Vbeta but diverse Valpha repertoire: functional and structural implications. J Mol Biol 2007; 372: 535–548.
  • Kim JA, Rao P, Graor H, Rothchild K, O'keefe C, Maciejewski JP. CDR3 spectratyping identifies clonal expansion within T-cell subpopulations that demonstrate therapeutic antitumor activity. Surgery 2004; 136: 295–302.
  • Talken BL, Bailey CW, Reardon SL, Caldwell CW, Hoffman RW. Structural analysis of TCR a and # chains from Human T-cell clones specific for small nuclear ribonucleoprotein polypeptides Sm-D, Sm-B and U1-70 kDa: TCR complementarity determining region 3 usage appears highly conserved. Scand J Immunol 2001; 54: 204–210.
  • Shimizudani N, Murata H, Keino H et al. Conserved CDR3 region of T cell receptor BY gene in lymphocytes from bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis. Clin Exp Immunol 2002; 129: 140–149.
  • May E, Dulphy N, Frauendorf E et al. Conserved TCR beta chain usage in reactive arthritis: evidence for selection by a putative HLA-B27-associated autoantigen. Tissue Antigens 2002; 60: 299–308.
  • Grunewald J, Halapi E, Wahlström J et al. T-cell expansions with conserved T-cell receptor # chain motifs in the peripheral blood of HLA-DRB1*0401 positive patients with necrotizing vasculitis. Blood 1998; 92: 3737–3744.
  • Gargiulo L, Lastraioli S, Cerruti G et al. Highly homologous T-cell receptor beta sequences support a common target for autoreactive T cells in most patients with paroxysmal nocturnal hemoglobi-nuria. Blood 2007; 109: 5036–5042.
  • Dudley ME, Wunderlich JR, Shelton TE, Even J, Rosenberg SA. Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients. J Immunother 2003; 26: 332–342.
  • Ishizuka J, Stewart-Jones GB, van der Merwe A, Bell JI, McMichael Ai, Jones EY. The structural dynamics and energetics of an immunodominant T cell receptor are programmed by its Vbeta domain. Immunity 2008; 28: 171–182.
  • Tynan FE, Burrows SR, Buckle AM et al. T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide. Nat Immunol 2005; 6: 1114–1122.
  • Archbold JK, Macdonald WA, Gras S et al. Natural micro-polymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition. J Exp Med 2009; 206: 209–219.
  • Bordoli L, Kiefer F, Arnold K, Benkert P, Battey J, Schwede T. Protein structure homology modeling using SWISS-MODEL workspace. Nat Protoc 2009; 4: 1–13.
  • Kaistha SD, Sinha R. Homology modeling of phosphoryl thymidine kinase of enterohemorrhagic Escherichia coli OH: 157. Bioinformation 2009; 3: 240–243.
  • Sauter P, Chehadeh W, Lobert PE et al. A part of the VP4 capsid protein exhibited by coxsackievirus B4 E2 is the target of antibodies contained in plasma from patients with type 1 diabetes. J Med Virol 2008; 80: 866–878.
  • Hillisch A, Pineda LF, Hilgenfeld R. Utility of homology models inthe drug discovery process. Drug Discov Today 2004; 9: 659–669.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.